NTRK2 and early-onset autosomal dominant Alzheimer disease: Liao J., Chen C., Ahn E.H., Liu X., Li H., Edgington-Mitchell L.E.,Lu Z., Ming S., Ye K. Targeting both BDNF/TrkB pathway and delta-secretase for treating Alzheimer’s disease.